Improvement of lymphocyte proliferation in human immunodeficiency virus infection after recombinant interleukin-2 treatment

Scandinavian Journal of Infectious Diseases

Volumn 31, Issue 5, 1999, Pages 437-442

  Afzelius, Pia ^a   Nielsen, Susanne Dam ^a   Nielsen, Jens Ole ^a   Hansen, John Erik Stig ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2 RECEPTOR; MESSENGER RNA; PHYTOHEMAGGLUTININ; PROTEIN P55; RECOMBINANT INTERLEUKIN 2;

ADULT; ARTICLE; CLINICAL ARTICLE; DONOR; FEMALE; FLOW CYTOMETRY; GENE INDUCTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE PROLIFERATION; MALE; MONONUCLEAR CELL; NORMAL HUMAN; POLYMERASE CHAIN REACTION;

ADULT; CD4 LYMPHOCYTE COUNT; DNA, COMPLEMENTARY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; INTERLEUKIN-2; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; RECEPTORS, INTERLEUKIN-2; RECOMBINANT PROTEINS; RNA, MESSENGER;

EID: 0345061685     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365549950163950     Document Type: Article

References (24)

1. Meyaard L, Otto SA, Keet IP, Van Lier RA, Miedema FA. Changes in cytokine secretion patterns of CD4+ T-cell clones in human immunodeficiency virus infection. Blood 1994; 84: 4262-8.
2. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, et al. Detection of three distinct patterns of T-helper dysfunction in asymptomatic HIV-seropositive patients: independence of CD4+ cell number and clinical staging. J Clin Invest 1989; 84: 1892-9.
3. Meroni L, Trabattoni D, Balotta C, Riva C, Gori A, Meroni M, et al. Evidence for type 2 cytokine production and lymphocyte activation in the early phases of HIV-1 infection. AIDS 1996; 10: 23-30.
4. Robb RJ, Smith KA. Heterogeneity of human T-cell growth factor(s) due to variable glycosylation. Mol Immunol 1981; 18: 1087-94.
5. Smith KA. T-cell growth factor. Immunol Rev 1980; 51: 337-57.
6. Morgan DA, Ruscetti FW, Gallo RC. Selective in vitro growth of T-lymphocytes from normal human bone marrow. Science 1976; 193: 1007-8.
7. Ciobanu N, Welte K, Kruger G, Venuta S, Gold J, Feldman P, et al. Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correlation by interleukin 2. J Clin Immunol 1983; 3: 332-40.
8. Hofmann B, Lindhardt BO, Gerstoft J, Petersen CS, Platz P, Ryder LP, et al. Lymphocyte transformation response to pokeweed mitogen as a predictive marker for development of AIDS and AIDS related symptoms in homosexual men with HIV antibodies. Br Med J 1987; 295: 293-6.
9. Hofmann B, Jakobsen KD, Ødum N, Dickmeiss E, Platz P, Ryder LP, et al. HIV-induced immunodeficiency: relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly responses via CD2/phytohemagglutinin pathway. J Immonol 1989; 142: 1874-80.
10. Hofmann B, Nishanian P, Nguyen T, Liu M, Fahay JL. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS 1993; 7: 659-64.
11. Kinter A, Fauci AS. Interleukin-2 and human immunodeficiency virus infection: pathogenic mechanisms and potential for immunologic enhancement. Immunol Res 1996; 15: 1-15.
12. Giorgi JV, Fahay JL, Smith DC, Hultin LE, Cheng HL, Mitsuyasu RT, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987; 138: 3725-30.
13. Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, Mann DL, et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals. Nature 1989; 339: 383-5.
14. Kelleher, Car A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173: 321-9.
15. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT Jr, Falloon J, et al. Sustained increases in CD4+ T-Lymphocytes in HIV-infected patients with intermittent continuous infusion interleukin-2 therapy: a preliminary report. N Engl J Med 1995; 332: 567-75.
16. Nielsen SD, Nielsen JO, Hansen J-ES. In vitro separation and expansion of CD4 lymphocytes from HIV-infected individuals without activation of HIV infection. J Immunol Meth 1997; 200: 107-12.
17. Afzelius P, Nielsen SD, Nielsen JO, Hansen J-ES. The serotonin analogue buspirone increases the function of PBMC from HIV-infected individuals in vitro. Scand J Infect Dis 1997; 29: 117-20.
18. Lipkowitz S, Green WC, Rubin AL, Novogrodsky A, Stenzel KH. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate. J Immunol 1984; 132: 31-7.
19. Eugen-Olsen J, Afzelius P, Andresen L, Iversen J, Kronborg G, Aabech P. et al. Serotonin modulates immune function in T-cells from HIV-seropositive subjects. Clin Immunol Immunopathol 1997; 84: 115-21.
20. Nielsen SD, Afzelius P, Ersbøll A, Nielsen JO, Hansen J-ES. Expression of activation antigens CD69 and CD25 predicts functionality of vitro expanded PBMC from healthy donors and HIV-infected patients. Clin Exp Immunol Clin Exp Immunol 1998; 114: 66-72.
21. Siekevitz M, Josephs SF, Dukovich M, Peffer N, Wong-Staal F, Greene WC. Activation of HIV-1 LTR by T-cell mitogens and trans-activator protein of HTLV-I. Science 1987; 238: 1575-8.
22. Schønning K, Nielsen C, Iversen J, Nielsen JO, Hansen J-ES. Neutralizing antibodies in slowly progressing HIV-1 infection J Acquir Immune Defic Syndr Hum Retrovirol 1995; 10: 400-7.
23. Grabstein K, Dower S, Gillis S, Urdal D, Larsen A. Expression of interleukin 2, Interferon-(, and the IL 2 receptor by human peripheral blood lymphocytes. J Immunol 1986; 136: 4503-8.
24. Taniguchi T, Matsui H, Fujita T, Takaoka C, Kashima N, Yoshimoto R, et al. Structure and expression of a cloned cDNA of IL-2. Nature 1983; 302: 305-10.